Health Care & Life Sciences » Pharmaceuticals | Aptose Biosciences Inc.

Aptose Biosciences Inc. | Ownership

Companies that own Aptose Biosciences Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Morgan Stanley & Co. LLC
351,639
1.02%
183,300
0%
06/30/2018
Techinvest Ltd.
257,061
0.75%
14,290
1.02%
03/29/2018
DRW Securities LLC
123,900
0.36%
103,900
0.02%
06/30/2018
DWS Investment GmbH
77,801
0.23%
-28,800
0%
06/30/2018
Securities America Advisors, Inc.
60,000
0.17%
0
0%
06/30/2018
US Bancorp Asset Management, Inc.
30,300
0.09%
0
0%
06/30/2018
The Patriot Financial Group Insurance Agency LLC
28,500
0.08%
17,000
0.09%
06/30/2018
G1 Execution Services LLC
26,666
0.08%
26,666
0%
06/30/2018
Antipodean Advisors LLC
25,000
0.07%
0
0.08%
06/30/2018
Two Sigma Advisers LP
19,800
0.06%
19,800
0%
06/30/2018

About Aptose Biosciences

View Profile
Address
251 Consumers Road
Toronto Ontario M2J 4R3
Canada
Employees -
Website http://aptose.com
Updated 07/08/2019
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG'806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.